Form 4: ICAD Inc. Director Hedvig Hricak Acquires 30,000 Stock Options

Director Hedvig Hricak of ICAD Inc. has acquired 30,000 stock options, exercisable at $2.06, which vest quarterly over a 12-month period.

Summary

• Hedvig Hricak, a director at ICAD Inc., has reported the acquisition of 30,000 stock options.
• These options have an exercise price of $2.06 per share.
• The options were granted on January 3, 2025, and vest quarterly over a 12-month period.
• The options expire on January 3, 2035.
• The underlying security for these options is ICAD Inc. common stock.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of a stock option grant to a director. It is neither particularly positive nor negative, but indicates standard corporate practice.

Positives

• The acquisition of stock options by a director can be seen as a positive sign of confidence in the company's future performance.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's securities. It is a routine disclosure and does not indicate any specific industry trend.

Comparison to Industry Standards

• Stock option grants to directors are a common practice in publicly traded companies as part of their compensation packages.
• The vesting schedule of quarterly over 12 months is also a typical arrangement.
• The exercise price of $2.06 is specific to ICAD Inc. and would need to be compared to other companies in the same sector to assess its relative value.

Stakeholder Impact

• The stock option grant could be viewed positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

stock options, director, ICAD Inc., insider trading, equity, compensation